Emerald Health Therapeutics Settles Outstanding Amounts

Vancouver, British Columbia--(Newsfile Corp. - January 13, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it has settled all outstanding amounts owing to the original vendors (the "Vendors") in connection with Emerald's 2018 acquisition of Verdlite Sciences, Inc. ("Verdlite Sciences") and Verdlite Property Holdings, Inc. ("Verdlite Property" and, together with Verdlite Sciences, the "Subsidiaries").